eCARTv5 Clinical Deterioration Suite (eCART) vs PeraMobile and PeraWatch

Direct competitors — feature-level head-to-head below. Comparability 92/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

PeraMobile and PeraWatch

by PeraHealth (acquired by Spacelabs Healthcare)

AI Verdict

Both eCARTv5 and PeraHealth's solutions are FDA-cleared, AI-powered clinical decision support tools that integrate with EHRs to predict patient deterioration in hospitalized settings. eCARTv5 emphasizes embedded clinical pathways for care guidance and minimizing false alarms, whereas PeraHealth offers a broader suite with mobile access, system-wide surveillance, and retrospective analytics for quality improvement.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 if your primary goal is to leverage advanced AI for highly accurate, continuous prediction of severe clinical deterioration events like death or ICU transfer. This tool is ideal for institutions seeking an early warning system that not only identifies at-risk patients hours in advance but also provides embedded clinical pathways to standardize and guide immediate care interventions, while minimizing false alarms.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose PeraMobile and PeraWatch if…

Choose PeraMobile and PeraWatch if your organization requires a flexible, system-wide solution for real-time patient acuity monitoring, accessible across various platforms including mobile devices. This suite is particularly well-suited for healthcare providers who benefit from visual dashboards of patient trends, configurable warning states, and robust retrospective analytics to drive continuous quality improvement initiatives.

View PeraMobile and PeraWatch →

For a physician evaluating AI tools for clinical deterioration, eCARTv5 by AgileMD and PeraMobile/PeraWatch by PeraHealth (now Spacelabs Healthcare) both offer FDA-cleared, EHR-integrated solutions. eCARTv5 excels at continuous, real-time risk assessment for hospitalized adult patients, specifically predicting death or ICU transfer. Its key differentiator lies in its embedded clinical pathways, which guide care directly based on its predictions, and its ability to minimize false alarms. This tool is best suited for hospitals seeking a comprehensive deterioration suite that not only predicts risk but also provides actionable guidance within existing workflows.

PeraMobile and PeraWatch, powered by the Rothman Index, focus on identifying at-risk patients sooner through real-time patient acuity scoring and predictive analytics. A key practical difference is its emphasis on mobile access for clinicians and system-wide virtual surveillance, allowing for on-the-go monitoring and configurable warning states. Physicians prioritizing broad patient surveillance, mobile accessibility, and retrospective analytics for quality improvement may find PeraHealth’s offerings more aligned with their needs. Ultimately, the choice hinges on whether the primary need is for guided clinical pathways integrated with predictions (eCARTv5) or for a robust, mobile-enabled surveillance system with strong analytical capabilities (PeraMobile/PeraWatch).

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	PeraMobile and PeraWatch
Pricing	Contact vendor for tailored quote.	Contact for pricing
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PeraMobile and PeraWatch

Tool B explicitly highlights 'Mobile access for on-the-go clinicians (PeraMobile)' and 'Visual dashboards of patient condition trends (PeraTrend)', which are key features for intuitive and flexible use by healthcare staff. While Tool A focuses on minimizing false alarms and clinician workload, Tool B's direct mention of mobile and visual tools suggests a potentially broader and more accessible user experience.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

Both tools are FDA-cleared and predict clinical deterioration. However, Tool A goes a step further by offering 'embedded clinical pathways for care guidance' in addition to predicting 'death or ICU transfer' and providing an 'early warning system (alerts hours before critical illness)'. This direct guidance within the workflow enhances its clinical actionability beyond just risk identification.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly available pricing details, both requiring direct contact for a tailored quote. Without specific cost information, it is impossible to conduct a head-to-head comparison of their value propositions or pricing transparency.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

Tool A explicitly states it is 'hipaa_compliant' and 'has_baa', along with being 'FDA-cleared' and 'Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems'. While Tool B is also FDA-cleared and integrates with EHRs, its HIPAA compliance and BAA status are listed as 'Likely', introducing a slight ambiguity compared to Tool A's explicit declarations, making Tool A's enterprise readiness more clearly defined.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

Tool A emphasizes its 'AI-powered' nature for continuous risk assessment and prediction, specifically highlighting its ability to 'Minimizes false alarms and clinician workload'. This focus on advanced AI and addressing a critical pain point like alert fatigue suggests a strong innovative approach in its core predictive engine. Tool B leverages the established Rothman Index, extending its application to mobile and system-wide surveillance, but Tool A's description points to more cutting-edge algorithmic development.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer sufficient comparative detail regarding the quality, comprehensiveness, or availability of support and documentation for either Tool A or Tool B. Both companies generally mention customer support and training, but without specific differentiating information, a tie is appropriate.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	PeraMobile and PeraWatch
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	PeraMobile and PeraWatch
Company	AgileMD	PeraHealth (acquired by Spacelabs Healthcare)
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Predictive analytics solutions, powered by the FDA-cleared Rothman Index, to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	Real-time patient acuity scoring (Rothman Index), Predictive analytics for patient deterioration, Integration with major EHR vendors, Mobile access for on-the-go clinicians (PeraMobile), System-wide virtual surveillance (PeraWatch), Configurable warning states and push notifications, Visual dashboards of patient condition trends (PeraTrend), Retrospective analytics for quality improvement (PeraAnalytics)

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and PeraMobile and PeraWatch.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental predictive model or index utilized by each tool?

AgileMD's eCARTv5 Clinical Deterioration Suite uses an AI-powered eCART score for continuous patient risk assessment. PeraMobile and PeraWatch from PeraHealth are powered by the FDA-cleared Rothman Index for real-time patient acuity scoring.

How do these tools assist clinicians in guiding care once a patient's risk is identified?

eCARTv5 guides care with embedded clinical pathways directly within the EHR system. PeraHealth's solutions focus on identifying at-risk patients sooner to enable earlier intervention and improve quality.

What specific patient outcomes do these tools aim to predict?

eCARTv5 specifically predicts the risk of clinical deterioration, defined as death or ICU transfer, in hospitalized adult patients. PeraHealth's tools aim to identify generally 'at-risk patients' sooner for earlier intervention.

What features are available for managing alerts and monitoring patient trends?

eCARTv5 provides an early warning system designed to minimize false alarms and clinician workload, with continuous risk assessment. PeraHealth offers configurable warning states, push notifications, and visual dashboards (PeraTrend) for patient condition trends, alongside system-wide virtual surveillance (PeraWatch).